Your browser doesn't support javascript.
loading
LncRNA HULC augments high glucose-associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy.
Sharma, Ankita; Chowdhury, Shibasish; Mukherjee, Sudeshna; Chowdhury, Rajdeep.
Afiliação
  • Sharma A; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India.
  • Chowdhury S; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India.
  • Mukherjee S; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India.
  • Chowdhury R; Department of Biological Sciences, Birla Institute of Technology and Science (BITS), Pilani, Rajasthan, India.
Biol Cell ; : e202400034, 2024 Jul 01.
Article em En | MEDLINE | ID: mdl-38949568
ABSTRACT
BACKGROUND INFORMATION One of the confounding factors in pancreatic cancer (PC) pathogenesis is hyperglycemia. The molecular mechanism by which high glucose (HG) influences PC severity is poorly understood. Our investigation delved into the impact of lncRNA highly upregulated in liver cancer (HULC) and its interaction with yes-associated protein (YAP) in regulating the fate of pancreatic ductal adenocarcinoma cells (PDAC) under HG-induced conditions. PDAC cells were cultured under normal or HG conditions. We thereafter measured the effect of HG on the viability of PDAC cells, their migration potential and drug resistance properties. The lncRNAs putatively dysregulated in PC and diabetes were shortlisted by bioinformatics analysis followed by wet lab validation of function.

RESULTS:

HG led to enhanced proliferation and drug refractoriness in PDAC cells. HULC was identified as one of the major deregulated lncRNAs following bioinformatics analysis. HULC was found to regulate the expression of the potent transcriptional regulator - YAP through selective histone modifications at the YAP promoter. siRNA-mediated ablation of HULC resulted in a concurrent decrease in YAP transcriptional activity. Importantly, HULC and YAP were found to co-operatively regulate the cellular homeostatic process autophagy, thus inculcating drug resistance and proliferative potential in PDAC cells. Moreover, inhibition of autophagy or YAP led to a decrease in HULC levels, suggesting the existence of an inter-regulatory feedback loop.

CONCLUSIONS:

We observed that HG triggers aggressive properties in PDAC cells. Mechanistically, up-regulation of lncRNA HULC resulted in activation of YAP and differential regulation of autophagy coupled to increased proliferation of PDAC cells.

SIGNIFICANCE:

Inhibition of HULC and YAP may represent a novel therapeutic strategy for PDAC. Furthermore, this study portrays the intricate molecular interplay between HULC, YAP and autophagy in PDAC pathogenesis.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biol Cell Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Biol Cell Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Índia País de publicação: Reino Unido